Attilio Orazi

33.4k citations
289 papers · 17.1k · 7 hit papers · h-index 51

Impact in

  • Hematology top 0.02%
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments
  • Genetics top 0.02%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment
    • Chronic Lymphocytic Leukemia Research

Papers in

    • Acute Myeloid Leukemia Research 102
    • Chronic Myeloid Leukemia Treatments 31
    • Hematopoietic Stem Cell Transplantation 18
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 92
    • Chronic Lymphocytic Leukemia Research 27

Attilio Orazi

277 papers receiving 16.5k citations

Attilio Orazi's Hit Papers

The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion 2018 · 403 citations
4030+9+19Years since publication2.0k4.0k6.0k

Peers

Attilio Orazi
Comparison fields: 5 of 139
  • Hematology 8.3k
  • Genetics 6.5k
  • Rheumatology 2.1k
  • Pathology and Forensic Medicine 2.1k
  • Immunology 2.2k
Replace Robert P. Hasserjian with:
Robert P. Hasserjian United States
Daniel A. Arber United States
James W. Vardiman United States
Wendy N. Erber Australia
Oliver G. Ottmann Germany
Dieter Hoelzer Germany
S Tura Italy
Richard D. Brunning United States
Charles Koller United States
Jaroslaw P. Maciejewski United States
Attilio Orazi relative to Robert P. Hasserjian United States Robert P. Hasserjian's profile →
Citations per field
00.5×1.5×
Robert P. Hasserjian · 1×
Citations per year

Countries citing papers authored by Attilio Orazi

Since Specialization
Citations

This map shows the geographic impact of Attilio Orazi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Attilio Orazi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Attilio Orazi more than expected).

Fields of papers citing papers by Attilio Orazi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Attilio Orazi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Attilio Orazi. The network helps show where Attilio Orazi may publish in the future.

Co-authors

The 25 scholars most cited alongside Attilio Orazi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Attilio Orazi Line = papers co-authored together Attilio Orazi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 289 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Hit paper breakdown →
20166327
2
The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation
Hit paper breakdown →
1997703
3
Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel
Hit paper breakdown →
2007624
4
European consensus on grading bone marrow fibrosis and assessment of cellularity.
Hit paper breakdown →
2005564
5
Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
Hit paper breakdown →
2012496
6
The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion
Hit paper breakdown →
2018403
7
The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes
Hit paper breakdown →
2015401
8 2000247
9 1993191
10 1990169
11
Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation.
1996167
12 1994143
13 1993135
14 2008114
15 1991113
16 1996110
17 1997110
18 2009109
19 2003104
20 200796

About Attilio Orazi

Attilio Orazi is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Molecular Biology and Rheumatology, having authored 289 papers that have together received 17.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (102 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (92 papers), Lymphoma Diagnosis and Treatment (46 papers), Eosinophilic Disorders and Syndromes (42 papers), Hematological disorders and diagnostics (35 papers), Chronic Myeloid Leukemia Treatments (31 papers), Chronic Lymphocytic Leukemia Research (27 papers) and Hematopoietic Stem Cell Transplantation (18 papers). The work is most often cited by research in Hematology (8.3k citations), Genetics (6.5k citations), Rheumatology (2.1k citations), Pathology and Forensic Medicine (2.1k citations) and Immunology (2.2k citations). Attilio Orazi has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Jürgen Thiele, Daniel A. Arber, Robert P. Hasserjian, James W. Vardiman, Clara D. Bloomfield, Michelle M. Le Beau, Mario Cazzola, Michael J. Borowitz, Hans Michael Kvasnicka and Giorgio Cattoretti. Their work appears in journals such as Blood, Modern Pathology, American Journal of Clinical Pathology, American Journal of Hematology and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact